Sanofi U.S. is the U.S. arm of Sanofi, a multinational pharmaceutical company. It lobbies on health-care and drug-pricing matters, including implementation of the Inflation Reduction Act drug-price rules, the 340B drug discount program, Medicare and Medicaid issues, orphan drug tax credits, and an excise tax tied to the Vaccine Injury Compensation Fund. It reports hiring Forbes-Tate and about $200,000 in recent filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CYNTHIA BROWN
The latest disclosures for this client.
FORBES-TATE
Q2FORBES-TATE
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FORBES-TATE
ELIZABETH GREER
FORBES-TATE
JEFFREY FORBES
FORBES-TATE
ZACHARY WILLIAMS
FORBES-TATE
FORBES-TATE
Q4FORBES-TATE
Q3FORBES-TATE
Q2FORBES-TATE
Q1